Denali Therapeutics
DNLI
#4088
Rank
C$3.11 B
Marketcap
$21.48
Share price
-6.65%
Change (1 day)
-23.67%
Change (1 year)

Denali Therapeutics (DNLI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$0.20 Billion

According to Denali Therapeutics 's latest financial reports the company's total liabilities are C$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Denali Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.20 B27.14%
2023-12-31C$0.16 B-71.23%
2022-12-31C$0.56 B0.68%
2021-12-31C$0.56 B-2.67%
2020-12-31C$0.57 B179.76%
2019-12-31C$0.20 B31.85%
2018-12-31C$0.15 B496.18%
2017-12-31C$26.3 M-94.64%
2016-12-31C$0.49 B576.28%
2015-12-31C$72.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.27 B 509.43% Jersey
C$3.15 B 1,411.64%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.02 M-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.17 B-15.56%๐Ÿ‡ฌ๐Ÿ‡ง UK